Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
42.98
-0.18 (-0.42%)
Apr 8, 2026, 2:41 PM EDT - Market open
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $2.57 billion as of April 8, 2026. Its market cap has increased by 148.81% in one year.
Market Cap
2.57B
Enterprise Value
2.12B
1-Year Change
148.81%
Ranking
Category
Stock Price
$42.98
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $2.57B, an increase of 163.88%. That is a compound annual growth rate of 36.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 2.58B | 182.40% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 2.44B |
| Sarepta Therapeutics | 2.44B |
| Veradermics | 2.40B |
| Celldex Therapeutics | 2.39B |
| Zai Lab | 2.30B |
| Adaptive Biotechnologies | 2.28B |
| Relay Therapeutics | 2.24B |
| Mineralys Therapeutics | 2.22B |